Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Assembly Biosciences (ASMB) Research & Development (2016 - 2025)

Assembly Biosciences (ASMB) has 11 years of Research & Development data on record, last reported at $16.6 million in Q3 2025.

  • For Q3 2025, Research & Development rose 22.73% year-over-year to $16.6 million; the TTM value through Sep 2025 reached $61.8 million, up 17.44%, while the annual FY2024 figure was $55.9 million, 14.38% up from the prior year.
  • Research & Development reached $16.6 million in Q3 2025 per ASMB's latest filing, up from $16.1 million in the prior quarter.
  • Across five years, Research & Development topped out at $18.6 million in Q1 2021 and bottomed at $10.8 million in Q3 2023.
  • Average Research & Development over 5 years is $15.3 million, with a median of $16.1 million recorded in 2025.
  • Peak YoY movement for Research & Development: tumbled 55.99% in 2021, then rose 29.83% in 2024.
  • A 5-year view of Research & Development shows it stood at $14.7 million in 2021, then grew by 14.28% to $16.9 million in 2022, then plummeted by 34.69% to $11.0 million in 2023, then rose by 29.75% to $14.3 million in 2024, then increased by 16.16% to $16.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Research & Development were $16.6 million in Q3 2025, $16.1 million in Q2 2025, and $14.9 million in Q1 2025.